Crossmark

Comment on “A Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of Adjunctive Brexpiprazole 2 mg Daily in Japanese Patients with Major Depressive Disorder”'

Crossref DOI link: https://doi.org/10.1007/s40263-024-01152-6

Published Online: 2025-01-02

Published Print: 2025-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wang, Chenxi https://orcid.org/0009-0003-2630-4723
Tian, Huichuan

Shang, Jin
License Information

Text and Data Mining valid from 2025-01-02

Version of Record valid from 2025-01-02
More Information

Article History

Accepted: 8 December 2024

First Online: 2 January 2025

Declarations

:

: No funding was received to assist with the preparation of this manuscript.

: The authors declare that they have no competing interests.

: Not applicable.

: Not applicable.

: Not applicable.

: Data sharing is not applicable to this article as no new data were created or analyzed in this study.

: Not applicable.

: C.W. designed this project and wrote the manuscript. H.T. collected the data. J.S. contributed to reviewing and editing the paper. All authors read and approved the final manuscript.

Document is current

Any future updates will be listed below